Rexahn Pharmaceuticals, Inc. (REXN)

[hopester]

Let me add:
1)The stock ran up ahead of the Biotech conference on the expectation that some announcement of partnering or other arrangement would be subsequently announced.
No such deal was made and may have disappointed some. However, the company did say they have had interest expressed by 2-3 companies and was now sifting and sorting thru them to see which is best for the company and it's shareholders. Indicated something would be announced by mid-year.
2)a simple pullback from quick recent gains is not unusual .

The trend is still positive and technical indicators are mostly in tact.
For now, the stock is merely consolidating.